Patient info Open main menu

Sofradex ear/eye drops solution – patient leaflet, side effects, dosage

Last updated: · Text from the MHRA, as of · About this document

Medicine status: Prescription only (POM) Details

Medicine strength:
500 microgram/ml + 50 microgram/ml + 5 mg/ml

Patient leaflet - Sofradex ear/eye drops solution

1. What Sofradex Drops are and what they are used for

Sofradex Ear/Eye Drops, Solution (called Sofradex Drops in this leaflet) contains three medicines called Framycetin sulphate, Gramicidin and Dexamethasone sodium metasulphobenzoate.

  • Framycetin sulphate and Gramicidin belong to a group of medicines called antibiotics. These work by killing the bacteria that is causing the infection.
  • Dexamethasone sodium

    metasulphobenzoate. This belongs to a group of medicines called steroids. It works by lowering inflammation

What Sofradex Drops are used for It is used in the eye(s) for:

  • Inflammation in the eye when prevention of bacterial infection is also needed. Signs include sore, red or swollen eyes.

    It is used in the ear(s) for:

    • Inflammation of the ear canal (otitis externa)

2. What you need to know before you use Sofradex Drops

Do not use Sofradex Drops and tell your doctor:

  • If you are allergic (hypersensitive) to framycetin sulphate, dexamethasone sodium metasulphobenzoate, gramicidin or any of the other ingredients of this medicine (listed in section 6 below).

    Signs of an allergic reaction include: a rash, swallowing or breathing problems, swelling of your lips, face, throat, tongue and worsening of redness, itching or swelling of the eye or eyelid.

  • Your eye or ear inflammation is due to an infection caused by a fungus or a virus.
  • You have untreated eye or ear infections caused by microorganisms that may be masked or enhanced by the steroids.
  • if you are using these drops in your eye and:

    • your eye inflammation is due to an

      infection called tuberculosis (TB)

    • you have pus in your eye(s)
    • you have eye pain or eyelid swelling

      or a red eye, the cause of which has not been diagnosed. Inappropriate use is potentially blinding.

      • you have glaucoma.
      • you have an ulcer in your eye(s)

        caused by the herpes simplex virus (herpetic keratitis).

      • if you are using these drops in your ear and:

        • you have pus in your ear(s).
        • you have a damaged (perforated)

          eardrum.

Do not use this medicine if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before using Sofradex Drops.

Warnings and precautions

Talk to your doctor or pharmacist before using Sofradex Drops if:

  • You experience blurred vision or other

    visual disturbances.

  • You have ototoxicity or family history

    of ototoxicity (harmful effects to ear) with signs and symptoms including ringing in ears, imbalance (associated with dizziness, nausea, and blurry vision), decreased hearing, hearing loss.

  • You know (or think) you have a

    mitochondrial disease (mutations in the parts of your cells which help make energy). These diseases may increase your risk of hearing loss with this product.

    Prolonged use may lead to allergy and the emergence of non-susceptible (resistant) bacteria. Repeated and prolonged use (more than 7 days) requires monitoring of intraocular pressure due to the risk of glaucoma, cataract formation or unsuspected infections. Prolonged use in children and infants may lead to the risk of partial or total deafness.

    Other medicines and Sofradex Drops

    Tell your doctor or pharmacist if you are taking or have recently taken or might take any other medicines.

    • Some medicines may increase the effects of Sofradex Drops and your doctor may wish to monitor you carefully if you are taking these medicines (including some medicines for HIV: ritonavir, cobicistat).

Pregnancy and breast-feeding

Talk to your doctor or pharmacist before using this medicine if:

  • You are pregnant, might become

    pregnant, or think you may be pregnant.

  • You are breast-feeding or planning to

    breast-feed.

    Driving and using machines

    You may have blurred eyesight straight after using Sofradex Drops. If this happens, do not drive or use any tools or machines until you can see clearly.

3. How to use Sofradex Drops

Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

How to use this medicine

  • This medicine can be used in the eye and the ear
  • Do not use this medicine for more than 7 days without talking to your doctor

Use in the eye

  • Wash your hands
  • Remove the cap on the bottle
  • Tilt your head back
  • Squeeze one or two drops inside the lower lid without touching your eye with the bottle
  • Close your eye
  • Wipe away any excess drops with a clean tissue
  • Always put the cap back on the bottle as soon as you have used it

ZENTIVA MATERIALNUMMER XXX XX

Use in the ear

  • Wash your hands
  • Remove the cap on the bottle
  • Tilt your head on one side
  • Squeeze two or three drops into your ear
  • Lie your head with your affected ear facing upwards for a few minutes
  • Wipe away any excess drops with a clean tissue
  • Always put the cap back on the bottle as soon as you have used it

How much to use

In the eye(s)

  • One or two drops in the affected eye six times a day or more if advised by your doctor
  • Keep using Sofradex Drops as instructed by your doctor

In the ear(s)

  • Two or three drops in the ear three or four times a day
  • Keep using Sofradex Drops as instructed by your doctor

    If you forget to use Sofradex Drops

    If you forget a dose, put some in as soon as you remember. However, if it is nearly time for the next dose, skip the missed dose. Do not use a double dose to make up for a forgotten dose.

    If you stop using Sofradex Drops

    Keep using these drops until your doctor tells you to stop. Otherwise, you could get an infection, or the inflammation could get worse.

    If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them

Stop using Sofradex Drops and see a doctor as soon as possible if:

  • You get any kind of skin problem, such as a rash or itching around your eyes or irritation, increased sweating, burning, stinging, itching or swelling or eczema of the eye or ear area.
  • Your eyes have problems focussing or develop a blind spot. You may have

    increased pressure in the eye (glaucoma).

    • You have difficulty seeing at night or notice that your eyesight is cloudy and fuzzy, or you see halos around lights. These could be signs of cataracts. This may occur after using the medicine for a long time.
    • You experience blurred vision.

Reporting of side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.

By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Sofradex Drops

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the label and carton after EXP. The expiry date refers to the last day of that month.

Store below 25°C. Do not refrigerate.

Sofradex Drops are sterile when you buy them, so you must not keep them for more than 28 days after opening the bottle.

Do not throw away any medicine via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.

6. Contents of the pack and other information

What Sofradex Drops contains

  • The eye drops contain the active substances: framycetin sulphate (0.5%w/v), dexamethasone sodium metasulphobenzoate (equivalent to 0.050% w/v of dexamethasone) and gramicidin (0.005%w/v)
  • The other ingredients are citric acid monohydrate, sodium citrate, lithium chloride, phenylethyl alcohol, industrial methylated spirit, polysorbate 80 and water for injection. Sodium hydroxide and hydrochloric acid are used for pH adjustment.

    What Sofradex Drops looks like and contents of the pack

    Sofradex Drops are clear colourless ear/ eye drops. The drops are also available in 5ml, 8ml and 10ml dropper bottles. Not all pack sizes may be marketed.

    Marketing Authorisation Holder and Manufacturer

    Marketing Authorisation Holder Neon Healthcare Ltd.

    8 The Chase, John Tate Road,

    Hertford,

    SG13 7NN

    United Kingdom

    Manufacturer

    Zentiva k.s.,

    U Kabelovny 130

    102 37 Prague 10,

    Czech Republic

    This leaflet does not contain all the information about your medicine. If you have any questions or are not sure about anything, ask your doctor or pharmacist.

    This leaflet was last revised in May 2025

ZENTIVA MATERIALNUMMER XXX XX

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: PL 45043/0115

Last revision stated in the text: May 2025 · MHRA data as of 13 October 2026

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Sofradex ear/eye drops solution

Prescription needed? Yes, prescription-only medicine (POM)
Active substances Gramicidin, Framycetin sulfate, Dexamethasone sodium metasulfobenzoate
Strength 500 microgram/ml + 50 microgram/ml + 5 mg/ml
Pharmaceutical form Ear/eye drops solution
How is it taken Auricular, Ocular
Pack sizes 8 ml
Is it available? Listed as available (NHS Dictionary of Medicines and Devices – not a record of current supplies)
Drug group (ATC)
  1. S Sensory organ drugs
    1. S02 Otologicals
      1. S02C Corticosteroids and antiinfectives in combination, otologic
        1. S02CA Corticosteroids and antiinfectives in combination
          1. S02CA06 dexamethasone and antiinfectives
Marketing authorisation PL 45043/0115
Codes GTIN 5000283659778 · BNF 12010100

Sources: the MHRA product information (products.mhra.gov.uk) and the NHS Dictionary of Medicines and Devices (dm+d), release 10.1.0 of 12 October 2026, NHS Business Services Authority. Contains public sector information licensed under the Open Government Licence v3.0.